Latest Articles
Chronic Pelvic Pain in Executives: What’s Really Behind It - Medical Tourism Magazine
Chronic Pelvic Pain in Executives: What’s Really Behind It Medical Tourism Magazine
Published: Dec. 3, 2025, 6:45 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - sharewise.com
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia sharewise.com
Published: Dec. 3, 2025, 5:04 a.m.
Young people to receive new information about women’s health - gov.wales
Young people to receive new information about women’s health gov.wales
Published: Dec. 3, 2025, 12:06 a.m.
Everything Delish's Jamie Milne Is Pregnant, Expecting Baby No. 2 with Husband Brandon (Exclusive) - AOL.com
Everything Delish's Jamie Milne Is Pregnant, Expecting Baby No. 2 with Husband Brandon (Exclusive) AOL.com
Published: Dec. 2, 2025, 8:08 p.m.
Everything Delish's Jamie Milne Is Pregnant, Expecting Her Second Baby with Husband Brandon (Exclusive) - People.com
Everything Delish's Jamie Milne Is Pregnant, Expecting Her Second Baby with Husband Brandon (Exclusive) People.com
Published: Dec. 2, 2025, 8 p.m.
Experts establish diagnostic criteria for primary dysmenorrhea - Contemporary OB/GYN
Experts establish diagnostic criteria for primary dysmenorrhea Contemporary OB/GYN
Published: Dec. 2, 2025, 4:47 p.m.
Amy Schumer Addresses Chris Fischer Split Speculation - TMZ
Amy Schumer Addresses Chris Fischer Split Speculation TMZ
Published: Dec. 2, 2025, 2:22 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire
Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan
Published: Dec. 2, 2025, 1:05 p.m.
Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics - Femtech Insider
Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics Femtech Insider
Published: Dec. 2, 2025, 1:03 p.m.
Link copied to clipboard!